协同作用的胺无形铁Ox矩阵为强大的氧气进化
Jiandong Hu1, Yangfan Liu1, Yanlin Jia1
1School of Materials Science and Engineering, Central South University, Changsha 410083, Hunan, P. R. China.
ACS applied materials & interfaces
|September 19, 2025
概括
无形氧化物纳米薄膜增强氧气进化反应催化. 这种协同兴奋剂战略提高了活动和稳定性,超过了商业催化剂.
科学领域:
- 材料科学 材料科学 材料科学
- 电化学 电化学 电化学
- 催化剂是一种催化剂.
背景情况:
- 氧化 (IrOx) 是酸氧演化反应 (OER) 的关键催化剂.
- 它们的性能受到催化活性和长期稳定性之间的权衡的限制.
- 开发稳定和活跃的OER催化剂对于能源应用至关重要.
研究的目的:
- 为了增强氧化物演化反应的氧化的催化活性和稳定性.
- 在无形氧化物矩阵中研究兴奋剂的协同效应.
- 为了克服基于的氧化物的内在性能限制.
主要方法:
- 通过酸盐辅助合成超薄的Ru-doped无形的IrOx纳米片.
- 用光谱分析 (例如XPS,XAS) 来描述材料的特性.
- 密度函数理论 (DFT) 计算以了解电子结构和反应机制.
主要成果:
- 合成了具有高表面积的超薄 (2.36 nm) Ru-doped 无形的 IrOx 纳米片.
- 原子分散的Ru剂通过电荷转移优化了IRD频段的电子结构.
- 优化的催化剂 (Ru0.0738-IrOx) 在225 mV超电位下达到10 mA cm−2,稳定时间>100小时.
- 该机制转向了稳定的吸附物进化途径,抑制了降解.
结论:
- 无形IrOx与Ru的协同兴奋剂为先进的OER催化剂提供了一个有希望的策略.
- 优化的催化剂的性能明显优于商业的IrO2和RuO2.
- 这种方法为克服基于的OER催化剂的稳定性-活性权衡提供了一条途径.
相关概念视频
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
12.6K
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
12.6K
Oxidative Cleavage of Alkenes: Ozonolysis
12.8K
In ozonolysis, ozone is used to cleave a carbon–carbon double bond to form aldehydes and ketones, or carboxylic acids, depending on the work-up.
Ozone is a symmetrical bent molecule stabilized by a resonance structure.
Ozone is a symmetrical bent molecule stabilized by a resonance structure.
12.8K
Redox Equilibria: Overview
1.5K
A reduction-oxidation reaction is commonly called a redox reaction. In a redox reaction, electrons are transferred from one species to another rather than being shared between or among atoms. The reducing agent or reductant is the species that loses electrons and gets oxidized in the process. The species that gains electrons and gets reduced in the process is the oxidizing agent or oxidant. Redox reactions are represented as two separate equations called half-reactions, where one equation...
1.5K
Phase I Oxidative Reactions: Overview
715
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
715
Oxidation of Alkenes: Syn Dihydroxylation with Potassium Permanganate
16.4K
Alkenes can be dihydroxylated using potassium permanganate. The method encompasses the reaction of an alkene with a cold, dilute solution of potassium permanganate under basic conditions to form a cis-diol along with a brown precipitate of manganese dioxide.
16.4K
Oxidation-Reduction Reactions
75.1K
Oxidation–Reduction Reactions
75.1K


